UBS Group AG Reduces Stock Position in Molina Healthcare, Inc $MOH

UBS Group AG decreased its position in Molina Healthcare, Inc (NYSE:MOH) by 66.6% in the 4th quarter, HoldingsChannel reports. The firm owned 201,922 shares of the company’s stock after selling 402,012 shares during the period. UBS Group AG’s holdings in Molina Healthcare were worth $35,042,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in MOH. Blue Trust Inc. grew its holdings in shares of Molina Healthcare by 23.8% during the fourth quarter. Blue Trust Inc. now owns 322 shares of the company’s stock worth $56,000 after buying an additional 62 shares in the last quarter. Asset Management One Co. Ltd. raised its position in shares of Molina Healthcare by 0.3% in the third quarter. Asset Management One Co. Ltd. now owns 22,737 shares of the company’s stock valued at $4,351,000 after buying an additional 66 shares during the last quarter. Applied Finance Capital Management LLC lifted its stake in shares of Molina Healthcare by 5.7% during the third quarter. Applied Finance Capital Management LLC now owns 1,408 shares of the company’s stock valued at $269,000 after buying an additional 76 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Molina Healthcare by 0.7% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,668 shares of the company’s stock valued at $2,616,000 after buying an additional 92 shares during the period. Finally, Tokio Marine Asset Management Co. Ltd. boosted its position in Molina Healthcare by 5.0% during the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 2,025 shares of the company’s stock worth $388,000 after acquiring an additional 96 shares during the last quarter. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts have commented on MOH shares. Cantor Fitzgerald lowered their target price on shares of Molina Healthcare from $180.00 to $144.00 and set a “neutral” rating for the company in a research note on Monday, February 9th. Barclays raised their price objective on Molina Healthcare from $133.00 to $161.00 and gave the stock an “underweight” rating in a report on Friday, April 24th. The Goldman Sachs Group dropped their target price on Molina Healthcare from $167.00 to $124.00 and set a “neutral” rating for the company in a research note on Wednesday, February 11th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $129.00 target price on shares of Molina Healthcare in a research report on Friday, April 24th. Finally, Zacks Research upgraded Molina Healthcare from a “strong sell” rating to a “hold” rating in a report on Monday, April 20th. Three equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, Molina Healthcare currently has an average rating of “Hold” and an average price target of $169.60.

Molina Healthcare Stock Down 3.0%

Shares of MOH opened at $186.07 on Friday. Molina Healthcare, Inc has a fifty-two week low of $121.06 and a fifty-two week high of $333.00. The company’s fifty day moving average is $152.32 and its two-hundred day moving average is $158.52. The firm has a market cap of $9.69 billion, a PE ratio of 55.05 and a beta of 0.85. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.97.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.78. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The business had revenue of $10.80 billion during the quarter, compared to the consensus estimate of $10.91 billion. During the same period in the prior year, the firm posted $6.08 EPS. The business’s revenue for the quarter was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Analysts forecast that Molina Healthcare, Inc will post 5.21 earnings per share for the current year.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.